Prof. Sahar El Aidy from the Groningen Biomolecular Sciences and Biotechnology Institute (GBB) has won the ProDigest and CosmosID Gut Microbiome Therapeutic Innovation (GMTI) challenge out of almost fifty submissions from all over the world. Prof. El Aidy won the challenge with her research plan to investigate the ‘Role of anti-Parkinson’s Disease (PD) medication in enhancing bacterial overgrowth and community dynamics along the gastrointestinal tract’. She receives EUR 50,000 to conduct her project on ProDigest’s gastrointestinal SHIME® platform, an in vitro simulator of the gastrointestinal tract.
The aim of the project is to identify which gut bacterial metabolites can improve or impair communication with the host gut-brain axis and effectiveness of drug treatments. According to the reviewing committee, the project of Prof. El Aidy ‘addresses the growing question of the role of the microbiota in the Parkinson’s Disease and of drug-bugs interactions’.
Prof. Slotboom co-applicant in awarded ZonMw project application
On Thursday 10 June, a partial solar eclipse will be visible in the Netherlands. The eclipse will start at 11.21 a.m., with a peak at 12.27 p.m. At 1.36 p.m., the eclipse will be over. Eclipse glasses will be handed out at five locations.
De vier Nederlandse solar teams (Delft, Eindhoven, Groningen, Twente) slaan de handen ineen tegen klimaatverandering De studententeams bouwen hun eigen zonneauto’s en ontwikkelen innovaties voor een duurzamere toekomst, maar zien tegelijkertijd dat...
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether or not you want to accept other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information